Figure 2.
Distribution of VA for eyes with uveitis assigned to implant (grey) and systemic (white) therapy during the first 54 months of follow-up in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. *Calculated from the subset of eyes with uveitis at enrollment; § 20/20 = 85 letters, 20/40 = 70 letters, 20/200 = 35 letters; † Count Fingers (CF), Hand Motion (HM), Light Perception (LP) denoted as −10 letters; ‡ No Light Perception (NLP) denoted as −25 letters.